Andrew Gianoukakis
机构: Professor of Medicine, David Geffen School of Medicine at UCLA
每年引用次数
引用次数
引用: 4,829
H-指数: 28
I10-指数 : 42
出版物: 104
Comparison of diabetes care provided by an endocrinology clinic and a primary-care clinic.
Matthew C. Leinung, MD, FACE , Andrew G. Gianoukakis, MD , Daniel W. Lee, MD , Stacey L. Jeronis, MD
Endocrine Practice 6 ( 5) 361 -366
35
2000
426P A multicenter, randomized, double-blind, phase II study of lenvatinib (LEN) in patients (pts) with radioiodine-refractory differentiated thyroid cancer (RR-DTC) to evaluate the safety and efficacy of a daily oral starting dose of 18 mg vs 24 mg
M.S. Brose , Y. Panaseykin , B. Konda , C. de la Fouchardiere
Annals of Oncology 31
2020
1917P Pembrolizumab salvage add-on therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC) progressing on lenvatinib: Results of a multicenter phase II International Thyroid Oncology Group Trial
B. Haugen , J.D. French , F. Worden , B. Konda
Annals of Oncology 31
2020
Autonomous Thyroid Nodules Visualized by Positron Emission Tomography with 18F-Fluorodeoxyglucose: A Case Report and Review of the Literature
A.G. Gianoukakis , M. Karam , A. Cheema , J.A. Cooper
Thyroid 13 ( 4) 395 -399
13
2003
Treatment Patterns and Health Outcomes Among Patients with Radioiodine-Refractory Differentiated Thyroid Cancer in the United States and Western Europe.
A.G. Gianoukakis , N.M. Flores , C.L. Pelletier , M. DiBonaventura
Value in Health 17 ( 7)
2014
Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates.
M KARAM , A GIANOUKAKIS , P J FEUSTEL , A CHEEMA
Nuclear Medicine Communications 24 ( 5) 489 -495
53
2003
Subgroup analyses of a phase 3, multicenter, double-blind, placebo-controlled trial of Lenvatinib (E7080) in patients with 131I-refractory differentiated thyroid cancer
R Elisei , M Schlumberger , M Tahara , B Robinson
Annals of Oncology 25 iv355 -iv355
3
2014
Impact of duration of dose interruption on the efficacy of lenvatinib (LEN) in a phase 3 sudy in patients (pts) with radioiodine refractory differentiated thyroid cancer (RR-DTC)
M Tahara , MS Brose , L Wirth , T Suzuki
Annals of Oncology 28 v145 -v145
1
2017
Влияние прерывания терапии ленватинибом на общую эффективность лечения у пациентов с радиойодрезистентным дифференцированным раком щитовидной железы в исследовании III фазы
M Tahara , MS Brose , LJ Wirth , T Suzuki
Опухоли головы и шеи 9 ( 1) 38 -50
1
2019
Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates (vol 24, pg 489, 2003)
M Karam , A Gianoukakis , PJ Feustel , A Cheema
NUCLEAR MEDICINE COMMUNICATIONS 24 ( 7) 843 -843
2003
Severe hypophosphatemia due to a FGF-23 producing, metastatic, aggressive tumor of unknown primary
Jenny Qian Dai-Ju , Vijaya Surampudi , Teeranun Jirajariyavej , Andrew George Gianoukakis
ENDOCRINE REVIEWS 35 ( 3)
1
2014
Frequent hypoglycemia in Glycogen Storage Disease Type Ia
Teeranun Jirajariyavej , Akshay Bhanwarlal Jain , Andrew George Gianoukakis
ENDOCRINE REVIEWS 35 ( 3)
2014
THU265 A U-Shaped Relationship Between Undiagnosed Diabetes And Thyroid Function
Zara Zafar Alvi , Rudruidee Karnchanasorn , Horng-Yih Ou , Lee-Ming Chuang
Journal of the Endocrine Society 7 ( Supplement_1) bvad114. 701 -bvad114. 701
2023
Endothelial Cell Growth Promoting Activity in Graves' Disease Sera is Neutralized by Anti-Basic Fibroblast Growth Factor Antibodies in Patients with Fat Expansive but Not Infiltrative Orbitopathy.
Andrew G Gianoukakis , Mark B Zimering , Mark B Zimering , Elkin A Nunez
Endocrinology, diabetes and metabolism journal 3 ( 1)
2019
Ultrasensitive Detection of BRAF Mutations in Circulating Tumor DNA of Patients With Metastatic Thyroid Cancer
Filip Janku , Andrew G Gianoukakis , Helen J Huang , Mohamed A Gouda
Journal of the Endocrine Society 5
2021
Prolonged duration of response in lenvatinib responders with thyroid cancer.
Andrew G Gianoukakis , Corina E Dutcus , Nicolas Batty , Matthew Guo
Endocrine-related Cancer 25 ( 6) 699 -704
25
2018
Familial thyroid neoplasia: impact of technological advances on detection and monitoring.
Theresa Tran , Andrew G Gianoukakis
Current Opinion in Endocrinology, Diabetes and Obesity 17 ( 5) 425 -431
7
2010
Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy.
Andrew G Gianoukakis , Terry J Smith
Current Opinion in Endocrinology, Diabetes and Obesity 15 ( 5) 446 -452
28
2008
Parity and Risk of Thyroid Autoimmunity Based on the NHANES (2001-2002, 2007-2008, 2009-2010, and 2011-2012).
Marelle Yehuda , Chia-Hao Wang , Youngju Pak , Ken C Chiu
The Journal of Clinical Endocrinology and Metabolism 102 ( 9) 3437 -3442
6
2017
SAT-039 The Short-Term Effect of Multiple Kinase Inhibitor (Lenvatinib) on Spermatogenesis in Mice
Yanhe Lue , Andrew G Gianoukakis , Patrick T Fueger , Darren Teramoto
Journal of the Endocrine Society 4
2020